101 – 110 of 743
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Letter by Leffler Regarding Article, "Modified Citrus Pectin Prevents Blood-Brain Barrier Disruption in Mouse Subarachnoid Hemorrhage by Inhibiting Galectin-3"
(
- Contribution to journal › Letter
-
Mark
Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives
(
- Contribution to journal › Scientific review
-
Mark
Substituted polyfluoroaryl interactions with an arginine side chain in galectin-3 are governed by steric-, desolvation and electronic conjugation effects
(
- Contribution to journal › Article
-
Mark
Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use
(
- Contribution to journal › Article
-
Mark
Extracellular and intracellular small-molecule galectin-3 inhibitors
(
- Contribution to journal › Article
-
Mark
Human trophoblast requires galectin-3 for cell migration and invasion
(
- Contribution to journal › Article
-
Mark
Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles
(
- Contribution to journal › Article
-
Mark
Analysis of C3 nephritic factors by ELISA
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Analysis of anti-C1q autoantibodies by western blot
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation
(
- Contribution to journal › Article